+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Cardiopulmonary Stress Testing Systems Market: Demand to Soar as Incidence of Coronary Artery Disease Rises, notes TMR

Posted on May 16, 2017

The global cardiopulmonary stress testing systems market displays moderate degree of rivalry between a large number of medium and large sized players, states Transparency Market Research (TMR). Presently, the global market for cardiopulmonary stress testing systems is led by Philips Healthcare and GE Healthcare, which conjointly account for a share of 70.2% in the overall market. 

These market players have been maintaining their supremacy owing to the CPET and SPECT systems they provide. The global market for cardiopulmonary stress testing systems is fragmented with reference to competition. As a more number of people suffer from cardiovascular disorders, the leading players are opting for collaborations, mergers, partnerships, product innovations, and acquisitions. 

For instance, Nihon Kohden India, an ancillary of Nihon Kohden Corporation, announced its acquisition of Span Diagnostics, Ltd., a hematology analyzer reagents firm based in India in April 2015. Along the same lines, in June 2015, Welch Allyn, Inc. announced its partnership with the Ohio University College of Nursery. 

Progressing at a conducive CAGR of 8.20% between 2015 and 2023, the global market for cardiopulmonary stress testing systems is slated to reach US$6.67 bn by the end of 2023. 

Higher Customizability, Flexibility Places CPET Systems at Fore 

By product, the global market for cardiopulmonary stress testing systems was led by CPET systems segment in 2014. It is expected to retain its leading position over the forthcoming period as well, advancing at a CAGR of 8.5% between 2015 and 2023. The distinguished growth of this segment can be attributed to greater acceptance of CPET systems by healthcare professionals due to the high flexibility, customizability, and ease of maintenance of these systems. By geography, North America is expected to attain the largest revenue worth US$2.4 bn by the end of 2023. 

High Prevalence of Cardiovascular Diseases Fires up Demand 

The augmenting prevalence of cardiovascular diseases is responsible for the progressive growth of the global market for cardiopulmonary stress testing systems. Findings of the World Health Organization (WHO) reveal that the number of deaths caused by cardiovascular diseases was estimated at 17.3 million in 2008, which is expected to rise to 23.3 million by the end of 2030. 80% of these deaths occurred in low to middle income nations. 

The growing incidence of coronary artery diseases (CADs) has also been boosting the expansion of the market for cardiopulmonary stress testing systems. The growing elderly population worldwide and the increasing obesity rates have been contributing towards the expansion of the global market for cardiopulmonary stress testing systems as well. The U.K., the U.S., China, Japan, South Korea, Brazil, and Thailand are likely to witness a large geriatric population within a short span of time. This shift in demographics can result in a greater burden of coronary artery disease (CAD), because aged people are at a higher risk of cardiac disorders. 

On the flip side, the implementation of stringent legal provisions applicable to several medical devices with a view to bring down the costs of these products can hinder the growth of the market. The retarded growth of the SPECT MPI procedures, particularly in the U.S. can also restrict the growth of the market. However, the rising adoption of cardiopulmonary stress testing systems market in emerging economies of Latin America and Asia Pacific can nullify the impact of these deterrents. 

The information presented in this review is based on a Transparency Market Research report, titled, “Cardiopulmonary Stress Testing Systems Market (Product – Cardiopulmonary Exercise Testing (CPET) Systems (Portable CPET Systems and Desktop CPET Systems), Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, and SPECT) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”. 

Key Segments of the Cardiopulmonary Stress Testing Systems Market

Global Cardiopulmonary Stress Testing Systems Market, by Product Type

  • Cardiopulmonary Exercise Testing (CPET) Systems
    • Portable CPET Systems
    • Desktop CPET Systems
  • Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors
  • SPECT  

Global Cardiopulmonary Stress Testing Systems Market, by Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and North Africa
    • Saudi Arabia
    • UAE
    • Rest of MENA

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Back To Top